BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 35967878)

  • 1. The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.
    Almeida-Silva J; Menezes DS; Fernandes JMP; Almeida MC; Vasco-Dos-Santos DR; Saraiva RM; Viçosa AL; Perez SAC; Andrade SG; Suarez-Fontes AM; Vannier-Santos MA
    Front Cell Infect Microbiol; 2022; 12():926699. PubMed ID: 35967878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nitric oxide donor trans-[RuCl([15]aneN)NO] as a possible therapeutic approach for Chagas' disease.
    Guedes PM; Oliveira FS; Gutierrez FR; da Silva GK; Rodrigues GJ; Bendhack LM; Franco DW; Do Valle Matta MA; Zamboni DS; da Silva RS; Silva JS
    Br J Pharmacol; 2010 May; 160(2):270-82. PubMed ID: 20128813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo drug combination for the treatment of Trypanosoma cruzi infection: A multivariate approach.
    Strauss M; Rodrigues JHS; Lo Presti MS; Bazán PC; Báez AL; Paglini-Oliva P; Nakamura CV; Bustamante JM; Rivarola HW
    Exp Parasitol; 2018 Jun; 189():19-27. PubMed ID: 29726395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clomipramine and Benznidazole Act Synergistically and Ameliorate the Outcome of Experimental Chagas Disease.
    García MC; Ponce NE; Sanmarco LM; Manzo RH; Jimenez-Kairuz AF; Aoki MP
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3700-8. PubMed ID: 27067322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Miltefosine and Benznidazole Combination Improve Anti-
    Gulin JEN; Bisio MMC; Rocco D; Altcheh J; Solana ME; García-Bournissen F
    Front Cell Infect Microbiol; 2022; 12():855119. PubMed ID: 35865815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin Enhances the Anti-Trypanosoma cruzi Activity of Benznidazole-Based Chemotherapy in Acute Experimental Chagas Disease.
    Novaes RD; Sartini MV; Rodrigues JP; Gonçalves RV; Santos EC; Souza RL; Caldas IS
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3355-64. PubMed ID: 27001816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights of antiparasitic activity of sodium diethyldithiocarbamate against different strains of Trypanosoma cruzi.
    de Freitas Oliveira JW; Torres TM; Moreno CJG; Amorim-Carmo B; Damasceno IZ; Soares AKMC; da Silva Barbosa J; Rocha HAO; Silva MS
    Sci Rep; 2021 May; 11(1):11200. PubMed ID: 34045624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vitro and In Vivo Trypanosomicidal Action of Novel Arylimidamides against Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DG; Meuser MB; Demarque KC; Fulco TO; Araújo JS; Da Silva PB; Da Silva CF; Patrick DA; Bakunova SM; Bakunov SA; Tidwell RR; Oliveira GM; Britto C; Moreira OC; Soeiro MN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2425-34. PubMed ID: 26856830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thioridazine aggravates skeletal myositis, systemic and liver inflammation in Trypanosoma cruzi-infected and benznidazole-treated mice.
    Mendonça AAS; Gonçalves-Santos E; Souza-Silva TG; González-Lozano KJ; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD
    Int Immunopharmacol; 2020 Aug; 85():106611. PubMed ID: 32447223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Combination Therapy with Amiodarone and Low-Dose Benznidazole in a Mouse Model of Trypanosoma cruzi Acute Infection.
    Barbosa JMC; Pedra Rezende Y; de Melo TG; de Oliveira G; Cascabulho CM; Pereira ENGDS; Daliry A; Salem KS
    Microbiol Spectr; 2022 Feb; 10(1):e0185221. PubMed ID: 35138142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Aspects of the Coadministration of Sterol 14α-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
    Guedes-da-Silva FH; Batista DDGJ; Da Silva CF; Pavão BP; Batista MM; Moreira OC; Souza LRQ; Britto C; Rachakonda G; Villalta F; Lepesheva GI; Soeiro MNC
    ACS Infect Dis; 2019 Mar; 5(3):365-371. PubMed ID: 30625275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo activity of voriconazole and benznidazole combination on trypanosoma cruzi infection models.
    Gulin JEN; Eagleson MA; López-Muñoz RA; Solana ME; Altcheh J; García-Bournissen F
    Acta Trop; 2020 Nov; 211():105606. PubMed ID: 32598923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repurposing Strategy of Atorvastatin against Trypanosoma cruzi:
    Araujo-Lima CF; Peres RB; Silva PB; Batista MM; Aiub CAF; Felzenszwalb I; Soeiro MNC
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the anti-Trypanosoma cruzi activity in vitro and in vivo of silibinin and silibinin in association to benznidazole.
    Torchelsen FKVDS; Silva TM; Milagre MM; Silva RR; Reis LES; Branquinho RT; Silva GN; de Lana M
    Parasitol Res; 2021 Apr; 120(4):1511-1517. PubMed ID: 33236174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined treatment of heterocyclic analogues and benznidazole upon Trypanosoma cruzi in vivo.
    Batista Dda G; Batista MM; de Oliveira GM; Britto CC; Rodrigues AC; Stephens CE; Boykin DW; Soeiro Mde N
    PLoS One; 2011; 6(7):e22155. PubMed ID: 21814568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.
    Sesti-Costa R; Carneiro ZA; Silva MC; Santos M; Silva GK; Milanezi C; da Silva RS; Silva JS
    PLoS Negl Trop Dis; 2014 Oct; 8(10):e3207. PubMed ID: 25275456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of Ascorbic Acid in Association with Low-Dose Benznidazole in Treatment of Chagas Disease.
    Providello MV; Carneiro ZA; Portapilla GB; do Vale GT; Camargo RS; Tirapelli CR; de Albuquerque S
    Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29987143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
    Zanusso Junior G; Massago M; Kian D; Toledo MJO
    Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benznidazole, itraconazole and their combination in the treatment of acute experimental chagas disease in dogs.
    Cunha ELA; Torchelsen FKVDS; Cunha LM; de Oliveira MT; Fonseca KDS; Vieira PMA; Carneiro CM; de Lana M
    Exp Parasitol; 2019 Sep; 204():107711. PubMed ID: 31254494
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental benznidazole treatment of Trypanosoma cruzi II strains isolated from children of the Jequitinhonha Valley, Minas Gerais, Brazil, with Chagas disease.
    Oliveira-Silva JC; Machado-de-Assis GF; Oliveira MT; Paiva NC; Araújo MS; Carneiro CM; Martins-Filho OA; Martins HR; Lana Md
    Mem Inst Oswaldo Cruz; 2015 Feb; 110(1):86-94. PubMed ID: 25742267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.